Renal phenotype of low kallikrein rats

Kidney International

Volumn 59, Issue 6, 2001, Pages 2233-2242

  Madeddu, Paolo ^a,b,c,d,e   Vio, Carlos P ^a,b,c,d   Straino, Stefania ^a,b,c,d   Salis, Maria Bonaria ^a,b,c,d   Milia, Anna Franca ^a,b,c,d   Emanueli, Costanza ^a,b,c,d  

^a National Laboratory   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Chatolica Universidad   (Chile)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^e NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Arterial hypertension; Blood pressure; Glomerular filtration rate; Kinins; Renal blood flow

Indexed keywords

ANGIOTENSIN RECEPTOR; KALLIKREIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HYPERTENSION; INBRED STRAIN; KIDNEY FUNCTION; MALE; NONHUMAN; PHENOTYPE; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE HOMOGENATE;

EID: 0035014405     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590062233.x     Document Type: Article

References (29)

1. Clements JA: The glandular kallikrein family of enzymes: Tissue-specific expression and hormonal regulation. Endocr Rev 10:393-419, 1989
2. Bhoola KD, Figueroa CD, Worthy K: Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 44:1-80, 1992
3. Granger JP, Hall JE: Acute and chronic actions of bradykinin on renal function and arterial pressure. Am J Physiol 248:F87-F92, 1985
4. Berry TD, Hasstedt SJ, Hunt SC, et al: A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13:3-8, 1989
5. Pravanec M, Kren V, Kunes J, et al: Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 17:242-246, 1991
6. Keiser HR, Geller RG, Margolius HS, Pisano JJ: Urinary kallikrein in hypertensive animal models. Fed Proc 35:199-202, 1976
7. Bianchi G, Barber BR, Torielli L, Ferrari P: The Milan hyper tensive strain, in Textbook of Hypertension, edited by Swales JD, Oxford, Blackwell Scientific Publications, 1994, pp 457-461
8. Ferri C, Bellini C, Carlomagno A, et al: Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int 46:780-788, 1994
9. Alfie ME, Yang XP, Hess F, Carretero OA: Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem Biophys Res Commun 224:625-630. 1996
10. 2-receptor gene. Circulation 96:3570-3578, 1997
11. Hunt SC, Wu LL, Slattery ML, et al. Environmental determinants of urinary kallikrein excretion. Am J Hypertens 6:226-233, 1993
12. Hunt SC, Hasstedt SJ, Wu CC, Williams RR: A gene-environmental interaction between inferred genotype and potassium. Hypertension 22:161-168, 1993
13. Valdes G, Vio CP, Montero J, Avenda O: Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J Hum Hypertens 5:91-96, 1991
14. Fujita T, Hayashi I, Kumagai Y, et al: Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats. Br J Pharmacol 128:1275-1283, 1999
15. Krmar RT, Galarza CR, Ramirez JA, et al: Potassium supplementation and urinary kallikrein excretion in normotensive offspring of hypertensive parents. Am J Hypertens 11:1497, 1998
16. 2 receptor in SHR. Am J Physiol 276(3 Pt 2):F476-F484, 1999
17. Yayama K, Wang C, Chao L, Chao J: Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats. Hypertension 31:1104-1110, 1998
18. Murakami H, Yayama K, Chao L, Chao J: Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats. Kidney Int 53:1305-1313, 1998
19. Chao J, Zhang JJ, Lin KF, Chao L: Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney Int 54:1250-1260, 1998
20. Madeddu P, Varoni MV, Demontis MP, et al: Urinary kallikrein: A marker of blood pressure sensitivity to salt. Kidney Int 49:1422-1427, 1996
21. Emanueli C, Madeddu P: Role of the kallikrein-kinin system in the maturation of cardiovascular phenotype. Am J Hypertens 12:988-999, 1999
22. Madeddu P, Varoni MV, Demontis MP, et al: Kallikrein-kinin system and blood pressure sensitivity to salt. Hypertension 29(1 Pt 2):471-477, 1997
23. Figueroa CD, Caorsi I, Subiabre J, Vio CP: Immunoreactive kallikrein localization in the rat kidney: An immuno electron microscopic study. J Histochem Cytochem 32:117-121, 1984
24. 2 receptor knockout mice. Circulation 100:2359-2365, 1999
25. Madeddu P, Anania V, Varoni MV, et al: Prevention by blockade of angiotensin subtype 1-receptors of the development of genetic hypertension but not its heritability. Br J Pharmacol 115:557-562, 1995
26. Madeddu P, Glorioso N, Soro A, et al: Effect of a kinin antagonist on renal function and haemodynamics during alterations in sodium balance in conscious normotensive rats. Clin Sci (Colch) 78:165-168, 1990
27. Schneider K, Gross V, Lippoldt A, Luft FC: Exaggerated natriuresis in transgenic (mRen2)27 rats. J Hypertens 15:1041-1048, 1997
28. Majima M, Yoshida O, Mihara H, et al: High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension 22:705-714, 1986
29. Madeddu P, Oppes M, Soro A, et al: The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. J Hypertens 5:581-586, 1987